Skip to main content
Premium Trial:

Request an Annual Quote

Floragenex, NCGR Team on Crop Marker Collaboration

NEW YORK (GenomeWeb News) – Floragenex today announced that it is collaborating with the non-profit National Center for Genome Resources to provide services for customers with a specific focus on discovering new markers in crops.

The collaboration will partner Floragenex's genomic discovery and application tools with NCGR's Illumina sequencing and bioinformatics capabilities.

"The costs and capabilities of DNA sequencing are now reaching the threshold where a new segment of agricultural companies and academic researchers are looking to apply the tools of genomics to their breeding and research activities," Floragenex CEO Nathan Lillegard said in a statement. "Working with NCGR gives Floragenex a collaborative technology partner that brings world class capabilities to the challenges of genetic discovery for our customers."

Floragenex is based in Eugene, Ore., and is a spinout of the University of Oregon.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.